Grant: Master's Award: Canada Graduate Scholarships
University of Ottawa
$17,500.00
ICD-11 Guidelines for Depressive Episode Severity: An Examination of Concurrent Validity
EF 2018-19
Résumé
Depression, one of the most common mental disorders in Canada, is associated with substantial burden on the individual and society. Current treatment decisions rely on an accurate assessment of depression severity without a universal definition of severity. The World Health Organization is working on the 11th revision of the International Classification of Diseases and Related Health Conditions (ICD-11), with the goal of improving its clinical practicality. The ICD-11 outlines a definition for depressive severity, and as such, it is important to examine how well the new guidelines measure depressive severity compared to a well-established depression tool. The present study aims to examine how well clinicians’ depressive episode severity ratings proposed in ICD-11 compare to the severity levels on the Beck Depression Inventory (BDI-II), a gold standard self-report questionnaire. Data from participants assessed for mood disorders at the Royal Ottawa Mental Health Centre as part of a larger ICD-11 clinical field trial, who were given a diagnosis of a depressive episode and completed the BDI-II, will be included. Both the ICD-11 and the BDI-II define depressive severity using three levels: mild, moderate and severe, and the relationship between the two scales will be analyzed. For instance, do most of the participants assigned a ‘severe’ rating on the ICD-11 also receive a ‘severe’ rating on the BDI-II for depressive episode? Determining the relationship between the two severity rating scales will provide useful information on how helpful the ICD-11 guidelines will be for clinicians in defining depressive severity among Canadian patients. This is especially relevant to public health, given Canada currently uses the ICD for health statistics.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
411257
Name
Montoya Madeline
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
ICD-11 Guidelines for Depressive Episode Severity: An Examination of Concurrent Validity
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Beck Depression Inventory-Ii (Bdi-Ii); Clinical Utility; Depression; Depressive Episode; Icd-11, Concurrent Validity; International Classification Of Diseases (Icd),
Abstract
Depression, one of the most common mental disorders in Canada, is associated with substantial burden on the individual and society. Current treatment decisions rely on an accurate assessment of depression severity without a universal definition of severity. The World Health Organization is working on the 11th revision of the International Classification of Diseases and Related Health Conditions (ICD-11), with the goal of improving its clinical practicality. The ICD-11 outlines a definition for depressive severity, and as such, it is important to examine how well the new guidelines measure depressive severity compared to a well-established depression tool. The present study aims to examine how well clinicians’ depressive episode severity ratings proposed in ICD-11 compare to the severity levels on the Beck Depression Inventory (BDI-II), a gold standard self-report questionnaire. Data from participants assessed for mood disorders at the Royal Ottawa Mental Health Centre as part of a larger ICD-11 clinical field trial, who were given a diagnosis of a depressive episode and completed the BDI-II, will be included. Both the ICD-11 and the BDI-II define depressive severity using three levels: mild, moderate and severe, and the relationship between the two scales will be analyzed. For instance, do most of the participants assigned a ‘severe’ rating on the ICD-11 also receive a ‘severe’ rating on the BDI-II for depressive episode? Determining the relationship between the two severity rating scales will provide useful information on how helpful the ICD-11 guidelines will be for clinicians in defining depressive severity among Canadian patients. This is especially relevant to public health, given Canada currently uses the ICD for health statistics.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Montoya, Madeline
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~